Pair Name | Maslinic acid, Gemcitabine | ||
Phytochemical Name | Maslinic acid (PubChem CID: 73659 ) | ||
Anticancer drug Name | Gemcitabine (PubChem CID: 60750 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Maslinic acid, Gemcitabine | |||
Disease Info | [ICD-11: 2C94] | Bladder cancer | Investigative | |
Biological Phenomena | Induction-->Apoptosis | |||
Gene Regulation | Down-regulation | Expression | BAX | hsa581 |
Down-regulation | Expression | BCL2 | hsa596 | |
Down-regulation | Expression | CCND1 | hsa595 | |
Down-regulation | Expression | MMP2 | hsa4313 | |
Down-regulation | Expression | MMP9 | hsa4318 | |
Down-regulation | Activity | NFKB1 | hsa4790 | |
In Vitro Model | EH-GB1 | Gallbladder carcinoma | Homo sapiens (Human) | CVCL_IU73 |
EH-GB2 | Gallbladder carcinoma | Homo sapiens (Human) | CVCL_6899 | |
GBC-SD | Gallbladder carcinoma | Homo sapiens (Human) | CVCL_6903 | |
In Vivo Model | EH-GB2 tumor cells were subcutaneously injected into the mice (2×10⁶ cells/mouse). | |||
Result | The results suggest that MA potentiates the antitumor effects of GEM in human GBC cell lines by suppressing the activation of NF-κB and its dowstream gene products, which are involved in survival signaling. |
No. | Title | Href |
---|---|---|
1 | Maslinic acid potentiates the antitumor activities of gemcitabine in vitro and in vivo by inhibiting NF-κB-mediated survival signaling pathways in human gallbladder cancer cells. Oncol Rep. 2015 Apr;33(4):1683-90. doi: 10.3892/or.2015.3755. | Click |